Intellia Therapeutics Inc... (NTLA)
7.32
0.67 (9.99%)
At close: Apr 02, 2025, 3:59 PM
6.68
-8.68%
After-hours: Apr 02, 2025, 07:59 PM EDT
Intellia Therapeutics Cash Flow Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
| Net Income | -481.19M | -481.19M | -474.19M | -267.89M | -134.23M | -99.53M | -85.34M | -67.54M | -31.63M | -12.4M | -14.31M |
| Depreciation & Amortization | -16.92M | 8.98M | 7.57M | 6.89M | 6.31M | 5.59M | 4.46M | 2.99M | 1.1M | 328K | 4.5K |
| Stock-Based Compensation | 134.05M | 134.05M | 91.4M | 47.01M | 19.9M | 15.09M | 17.05M | 15.32M | 6.71M | 1.31M | 462K |
| Other Working Capital | -22.86M | -54.97M | -47.55M | -31.36M | 45.12M | -27.12M | -3.94M | -12.99M | 67.97M | 9.67M | 1.03M |
| Other Non-Cash Items | -30.02M | -3.47M | 95.8M | 2.94M | 573K | -3.72M | -601K | 166K | 6.71M | 9K | 9.33M |
| Deferred Income Tax | n/a | n/a | n/a | 8.93M | n/a | n/a | n/a | n/a | -6.7M | -1.01M | n/a |
| Change in Working Capital | n/a | -52.45M | -53.87M | -22.9M | 57.53M | -20.66M | 3.18M | -16.21M | 59.91M | 10M | 1.03M |
| Operating Cash Flow | -394.09M | -394.09M | -333.29M | -225.03M | -49.91M | -103.24M | -61.26M | -65.28M | 36.11M | -1.76M | -3.48M |
| Capital Expenditures | -13.98M | -13.98M | -58.39M | -12.76M | -3.58M | -6.79M | -6.36M | -10.09M | -6.17M | -2.55M | -412.5K |
| Acquisitions | n/a | n/a | -44.68M | -3M | 210.9M | -31.97M | 131K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -904.46M | -904.46M | -429.03M | -1.02B | -473.7M | -297.03M | -254.56M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 893.73M | 887.1M | 647.58M | 485.6M | 262.8M | 329M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -6.62M | n/a | 44.83M | -538.02M | -210.9M | 31.97M | 131K | -10.1K | n/a | n/a | -450K |
| Investing Cash Flow | -31.35M | -31.35M | 160.31M | -550.78M | -214.49M | 25.18M | -260.78M | -10.09M | -6.17M | -2.55M | -862.5K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.67M | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 8.85M | 10.53M | 17.17M | 43.12M | 13.13M | 4.18M | 11.67M | 1.98M | -3.1M | -1.7M | 19.11M |
| Financial Cash Flow | 185.75M | 130.32M | 582.96M | 736.69M | 371.78M | 76.43M | 40.22M | 142.98M | 167.3M | 70.29M | 19.11M |
| Net Cash Flow | -295.11M | -295.11M | 409.98M | -39.12M | 107.38M | -1.63M | -281.82M | 67.61M | 197.25M | 65.97M | 14.77M |
| Free Cash Flow | -408.07M | -408.07M | -391.68M | -237.79M | -53.5M | -110.03M | -67.61M | -75.37M | 29.94M | -4.32M | -3.9M |